Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maureen F Zakowski
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
PLoS Medicine
Biochemistry
Biotechnology
Molecular Biology
Cell Biology
Medicine
Related publications
Prospective Assessment of Discontinuation and Reinitiation of Erlotinib or Gefitinib in Patients With Acquired Resistance to Erlotinib or Gefitinib Followed by the Addition of Everolimus
Clinical Cancer Research
Cancer Research
Oncology
Atorvastatin Overcomes Gefitinib Resistance in KRAS Mutant Human Non-Small Cell Lung Carcinoma Cells
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Synergistic Effect of Afatinib With Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib
PLoS ONE
Multidisciplinary
Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
ARID1A Gene Driver Mutations in Lung Adenocarcinomas
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Effect of KRAS Exon 2 Mutations on Antitumor Activity of Afatinib and Gefitinib
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology
A Case of Small Cell Lung Cancer Transformation From EGFR-Mutant Lung Adenocarcinoma With Primary Resistance to Gefitinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
The Impact of Initial Gefitinib or Erlotinib Versus Chemotherapy on Central Nervous System Progression in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
Clinical Cancer Research
Cancer Research
Oncology
Phase II Trials of Erlotinib or Gefitinib in Patients With Recurrent Meningioma
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
